I haven’t been too happy with my blood work with CLL, but I try to enjoy what I can — including apples during fall.

Among patients with ER-positive/HER2-negative advanced breast cancer, treatment with camizestrant in combination with Kisqali ...

Adjuvant Lynparza remains beneficial for patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast cancer, study results have shown.

Jaypirca showed superior progression-free survival and lower discontinuation rates versus standard treatments in patients ...

Autologous stem cell transplant plus Rituxan did not improve survival outcomes in certain patients with mantle cell lymphoma ...